Global Influenza Subunit Vaccine Market Growth 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Influenza Subunit Vaccine Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Influenza Subunit Vaccine by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Influenza Subunit Vaccine by Country/Region, 2019, 2023 & 2030 2.2 Influenza Subunit Vaccine Segment by Type 2.2.1 Trivalent Vaccines 2.2.2 Tetravalent Vaccine 2.3 Influenza Subunit Vaccine Sales by Type 2.3.1 Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2024) 2.3.2 Global Influenza Subunit Vaccine Revenue and Market Share by Type (2019-2024) 2.3.3 Global Influenza Subunit Vaccine Sale Price by Type (2019-2024) 2.4 Influenza Subunit Vaccine Segment by Application 2.4.1 Aldult 2.4.2 Child 2.5 Influenza Subunit Vaccine Sales by Application 2.5.1 Global Influenza Subunit Vaccine Sale Market Share by Application (2019-2024) 2.5.2 Global Influenza Subunit Vaccine Revenue and Market Share by Application (2019-2024) 2.5.3 Global Influenza Subunit Vaccine Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Influenza Subunit Vaccine Breakdown Data by Company 3.1.1 Global Influenza Subunit Vaccine Annual Sales by Company (2019-2024) 3.1.2 Global Influenza Subunit Vaccine Sales Market Share by Company (2019-2024) 3.2 Global Influenza Subunit Vaccine Annual Revenue by Company (2019-2024) 3.2.1 Global Influenza Subunit Vaccine Revenue by Company (2019-2024) 3.2.2 Global Influenza Subunit Vaccine Revenue Market Share by Company (2019-2024) 3.3 Global Influenza Subunit Vaccine Sale Price by Company 3.4 Key Manufacturers Influenza Subunit Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Influenza Subunit Vaccine Product Location Distribution 3.4.2 Players Influenza Subunit Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Influenza Subunit Vaccine by Geographic Region 4.1 World Historic Influenza Subunit Vaccine Market Size by Geographic Region (2019-2024) 4.1.1 Global Influenza Subunit Vaccine Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Influenza Subunit Vaccine Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Influenza Subunit Vaccine Market Size by Country/Region (2019-2024) 4.2.1 Global Influenza Subunit Vaccine Annual Sales by Country/Region (2019-2024) 4.2.2 Global Influenza Subunit Vaccine Annual Revenue by Country/Region (2019-2024) 4.3 Americas Influenza Subunit Vaccine Sales Growth 4.4 APAC Influenza Subunit Vaccine Sales Growth 4.5 Europe Influenza Subunit Vaccine Sales Growth 4.6 Middle East & Africa Influenza Subunit Vaccine Sales Growth 5 Americas 5.1 Americas Influenza Subunit Vaccine Sales by Country 5.1.1 Americas Influenza Subunit Vaccine Sales by Country (2019-2024) 5.1.2 Americas Influenza Subunit Vaccine Revenue by Country (2019-2024) 5.2 Americas Influenza Subunit Vaccine Sales by Type (2019-2024) 5.3 Americas Influenza Subunit Vaccine Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Influenza Subunit Vaccine Sales by Region 6.1.1 APAC Influenza Subunit Vaccine Sales by Region (2019-2024) 6.1.2 APAC Influenza Subunit Vaccine Revenue by Region (2019-2024) 6.2 APAC Influenza Subunit Vaccine Sales by Type (2019-2024) 6.3 APAC Influenza Subunit Vaccine Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Influenza Subunit Vaccine by Country 7.1.1 Europe Influenza Subunit Vaccine Sales by Country (2019-2024) 7.1.2 Europe Influenza Subunit Vaccine Revenue by Country (2019-2024) 7.2 Europe Influenza Subunit Vaccine Sales by Type (2019-2024) 7.3 Europe Influenza Subunit Vaccine Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Influenza Subunit Vaccine by Country 8.1.1 Middle East & Africa Influenza Subunit Vaccine Sales by Country (2019-2024) 8.1.2 Middle East & Africa Influenza Subunit Vaccine Revenue by Country (2019-2024) 8.2 Middle East & Africa Influenza Subunit Vaccine Sales by Type (2019-2024) 8.3 Middle East & Africa Influenza Subunit Vaccine Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Influenza Subunit Vaccine 10.3 Manufacturing Process Analysis of Influenza Subunit Vaccine 10.4 Industry Chain Structure of Influenza Subunit Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Influenza Subunit Vaccine Distributors 11.3 Influenza Subunit Vaccine Customer 12 World Forecast Review for Influenza Subunit Vaccine by Geographic Region 12.1 Global Influenza Subunit Vaccine Market Size Forecast by Region 12.1.1 Global Influenza Subunit Vaccine Forecast by Region (2025-2030) 12.1.2 Global Influenza Subunit Vaccine Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Influenza Subunit Vaccine Forecast by Type (2025-2030) 12.7 Global Influenza Subunit Vaccine Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Ab&B BIO-TECH 13.1.1 Ab&B BIO-TECH Company Information 13.1.2 Ab&B BIO-TECH Influenza Subunit Vaccine Product Portfolios and Specifications 13.1.3 Ab&B BIO-TECH Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Ab&B BIO-TECH Main Business Overview 13.1.5 Ab&B BIO-TECH Latest Developments 13.2 Sanofi 13.2.1 Sanofi Company Information 13.2.2 Sanofi Influenza Subunit Vaccine Product Portfolios and Specifications 13.2.3 Sanofi Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Sanofi Main Business Overview 13.2.5 Sanofi Latest Developments 13.3 Seqirus, Inc 13.3.1 Seqirus, Inc Company Information 13.3.2 Seqirus, Inc Influenza Subunit Vaccine Product Portfolios and Specifications 13.3.3 Seqirus, Inc Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Seqirus, Inc Main Business Overview 13.3.5 Seqirus, Inc Latest Developments 13.4 Zhongyianke Biology 13.4.1 Zhongyianke Biology Company Information 13.4.2 Zhongyianke Biology Influenza Subunit Vaccine Product Portfolios and Specifications 13.4.3 Zhongyianke Biology Influenza Subunit Vaccine Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Zhongyianke Biology Main Business Overview 13.4.5 Zhongyianke Biology Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Influenza Subunit Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. Influenza Subunit Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Trivalent Vaccines Table 4. Major Players of Tetravalent Vaccine Table 5. Global Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units) Table 6. Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2024) Table 7. Global Influenza Subunit Vaccine Revenue by Type (2019-2024) & ($ million) Table 8. Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2024) Table 9. Global Influenza Subunit Vaccine Sale Price by Type (2019-2024) & (US$/Unit) Table 10. Global Influenza Subunit Vaccine Sale by Application (2019-2024) & (K Units) Table 11. Global Influenza Subunit Vaccine Sale Market Share by Application (2019-2024) Table 12. Global Influenza Subunit Vaccine Revenue by Application (2019-2024) & ($ million) Table 13. Global Influenza Subunit Vaccine Revenue Market Share by Application (2019-2024) Table 14. Global Influenza Subunit Vaccine Sale Price by Application (2019-2024) & (US$/Unit) Table 15. Global Influenza Subunit Vaccine Sales by Company (2019-2024) & (K Units) Table 16. Global Influenza Subunit Vaccine Sales Market Share by Company (2019-2024) Table 17. Global Influenza Subunit Vaccine Revenue by Company (2019-2024) & ($ millions) Table 18. Global Influenza Subunit Vaccine Revenue Market Share by Company (2019-2024) Table 19. Global Influenza Subunit Vaccine Sale Price by Company (2019-2024) & (US$/Unit) Table 20. Key Manufacturers Influenza Subunit Vaccine Producing Area Distribution and Sales Area Table 21. Players Influenza Subunit Vaccine Products Offered Table 22. Influenza Subunit Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global Influenza Subunit Vaccine Sales by Geographic Region (2019-2024) & (K Units) Table 26. Global Influenza Subunit Vaccine Sales Market Share Geographic Region (2019-2024) Table 27. Global Influenza Subunit Vaccine Revenue by Geographic Region (2019-2024) & ($ millions) Table 28. Global Influenza Subunit Vaccine Revenue Market Share by Geographic Region (2019-2024) Table 29. Global Influenza Subunit Vaccine Sales by Country/Region (2019-2024) & (K Units) Table 30. Global Influenza Subunit Vaccine Sales Market Share by Country/Region (2019-2024) Table 31. Global Influenza Subunit Vaccine Revenue by Country/Region (2019-2024) & ($ millions) Table 32. Global Influenza Subunit Vaccine Revenue Market Share by Country/Region (2019-2024) Table 33. Americas Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units) Table 34. Americas Influenza Subunit Vaccine Sales Market Share by Country (2019-2024) Table 35. Americas Influenza Subunit Vaccine Revenue by Country (2019-2024) & ($ millions) Table 36. Americas Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units) Table 37. Americas Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units) Table 38. APAC Influenza Subunit Vaccine Sales by Region (2019-2024) & (K Units) Table 39. APAC Influenza Subunit Vaccine Sales Market Share by Region (2019-2024) Table 40. APAC Influenza Subunit Vaccine Revenue by Region (2019-2024) & ($ millions) Table 41. APAC Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units) Table 42. APAC Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units) Table 43. Europe Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units) Table 44. Europe Influenza Subunit Vaccine Revenue by Country (2019-2024) & ($ millions) Table 45. Europe Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units) Table 46. Europe Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units) Table 47. Middle East & Africa Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units) Table 48. Middle East & Africa Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024) Table 49. Middle East & Africa Influenza Subunit Vaccine Sales by Type (2019-2024) & (K Units) Table 50. Middle East & Africa Influenza Subunit Vaccine Sales by Application (2019-2024) & (K Units) Table 51. Key Market Drivers & Growth Opportunities of Influenza Subunit Vaccine Table 52. Key Market Challenges & Risks of Influenza Subunit Vaccine Table 53. Key Industry Trends of Influenza Subunit Vaccine Table 54. Influenza Subunit Vaccine Raw Material Table 55. Key Suppliers of Raw Materials Table 56. Influenza Subunit Vaccine Distributors List Table 57. Influenza Subunit Vaccine Customer List Table 58. Global Influenza Subunit Vaccine Sales Forecast by Region (2025-2030) & (K Units) Table 59. Global Influenza Subunit Vaccine Revenue Forecast by Region (2025-2030) & ($ millions) Table 60. Americas Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units) Table 61. Americas Influenza Subunit Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions) Table 62. APAC Influenza Subunit Vaccine Sales Forecast by Region (2025-2030) & (K Units) Table 63. APAC Influenza Subunit Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions) Table 64. Europe Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units) Table 65. Europe Influenza Subunit Vaccine Revenue Forecast by Country (2025-2030) & ($ millions) Table 66. Middle East & Africa Influenza Subunit Vaccine Sales Forecast by Country (2025-2030) & (K Units) Table 67. Middle East & Africa Influenza Subunit Vaccine Revenue Forecast by Country (2025-2030) & ($ millions) Table 68. Global Influenza Subunit Vaccine Sales Forecast by Type (2025-2030) & (K Units) Table 69. Global Influenza Subunit Vaccine Revenue Forecast by Type (2025-2030) & ($ millions) Table 70. Global Influenza Subunit Vaccine Sales Forecast by Application (2025-2030) & (K Units) Table 71. Global Influenza Subunit Vaccine Revenue Forecast by Application (2025-2030) & ($ millions) Table 72. Ab&B BIO-TECH Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors Table 73. Ab&B BIO-TECH Influenza Subunit Vaccine Product Portfolios and Specifications Table 74. Ab&B BIO-TECH Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 75. Ab&B BIO-TECH Main Business Table 76. Ab&B BIO-TECH Latest Developments Table 77. Sanofi Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors Table 78. Sanofi Influenza Subunit Vaccine Product Portfolios and Specifications Table 79. Sanofi Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 80. Sanofi Main Business Table 81. Sanofi Latest Developments Table 82. Seqirus, Inc Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors Table 83. Seqirus, Inc Influenza Subunit Vaccine Product Portfolios and Specifications Table 84. Seqirus, Inc Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 85. Seqirus, Inc Main Business Table 86. Seqirus, Inc Latest Developments Table 87. Zhongyianke Biology Basic Information, Influenza Subunit Vaccine Manufacturing Base, Sales Area and Its Competitors Table 88. Zhongyianke Biology Influenza Subunit Vaccine Product Portfolios and Specifications Table 89. Zhongyianke Biology Influenza Subunit Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 90. Zhongyianke Biology Main Business Table 91. Zhongyianke Biology Latest Developments List of Figures Figure 1. Picture of Influenza Subunit Vaccine Figure 2. Influenza Subunit Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Influenza Subunit Vaccine Sales Growth Rate 2019-2030 (K Units) Figure 7. Global Influenza Subunit Vaccine Revenue Growth Rate 2019-2030 ($ millions) Figure 8. Influenza Subunit Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 9. Influenza Subunit Vaccine Sales Market Share by Country/Region (2023) Figure 10. Influenza Subunit Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 11. Product Picture of Trivalent Vaccines Figure 12. Product Picture of Tetravalent Vaccine Figure 13. Global Influenza Subunit Vaccine Sales Market Share by Type in 2023 Figure 14. Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2024) Figure 15. Influenza Subunit Vaccine Consumed in Aldult Figure 16. Global Influenza Subunit Vaccine Market: Aldult (2019-2024) & (K Units) Figure 17. Influenza Subunit Vaccine Consumed in Child Figure 18. Global Influenza Subunit Vaccine Market: Child (2019-2024) & (K Units) Figure 19. Global Influenza Subunit Vaccine Sale Market Share by Application (2023) Figure 20. Global Influenza Subunit Vaccine Revenue Market Share by Application in 2023 Figure 21. Influenza Subunit Vaccine Sales by Company in 2023 (K Units) Figure 22. Global Influenza Subunit Vaccine Sales Market Share by Company in 2023 Figure 23. Influenza Subunit Vaccine Revenue by Company in 2023 ($ millions) Figure 24. Global Influenza Subunit Vaccine Revenue Market Share by Company in 2023 Figure 25. Global Influenza Subunit Vaccine Sales Market Share by Geographic Region (2019-2024) Figure 26. Global Influenza Subunit Vaccine Revenue Market Share by Geographic Region in 2023 Figure 27. Americas Influenza Subunit Vaccine Sales 2019-2024 (K Units) Figure 28. Americas Influenza Subunit Vaccine Revenue 2019-2024 ($ millions) Figure 29. APAC Influenza Subunit Vaccine Sales 2019-2024 (K Units) Figure 30. APAC Influenza Subunit Vaccine Revenue 2019-2024 ($ millions) Figure 31. Europe Influenza Subunit Vaccine Sales 2019-2024 (K Units) Figure 32. Europe Influenza Subunit Vaccine Revenue 2019-2024 ($ millions) Figure 33. Middle East & Africa Influenza Subunit Vaccine Sales 2019-2024 (K Units) Figure 34. Middle East & Africa Influenza Subunit Vaccine Revenue 2019-2024 ($ millions) Figure 35. Americas Influenza Subunit Vaccine Sales Market Share by Country in 2023 Figure 36. Americas Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024) Figure 37. Americas Influenza Subunit Vaccine Sales Market Share by Type (2019-2024) Figure 38. Americas Influenza Subunit Vaccine Sales Market Share by Application (2019-2024) Figure 39. United States Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 40. Canada Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 41. Mexico Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 42. Brazil Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 43. APAC Influenza Subunit Vaccine Sales Market Share by Region in 2023 Figure 44. APAC Influenza Subunit Vaccine Revenue Market Share by Region (2019-2024) Figure 45. APAC Influenza Subunit Vaccine Sales Market Share by Type (2019-2024) Figure 46. APAC Influenza Subunit Vaccine Sales Market Share by Application (2019-2024) Figure 47. China Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 48. Japan Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 49. South Korea Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 50. Southeast Asia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 51. India Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 52. Australia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 53. China Taiwan Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 54. Europe Influenza Subunit Vaccine Sales Market Share by Country in 2023 Figure 55. Europe Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024) Figure 56. Europe Influenza Subunit Vaccine Sales Market Share by Type (2019-2024) Figure 57. Europe Influenza Subunit Vaccine Sales Market Share by Application (2019-2024) Figure 58. Germany Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 59. France Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 60. UK Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 61. Italy Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 62. Russia Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 63. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Country (2019-2024) Figure 64. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Type (2019-2024) Figure 65. Middle East & Africa Influenza Subunit Vaccine Sales Market Share by Application (2019-2024) Figure 66. Egypt Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 67. South Africa Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 68. Israel Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 69. Turkey Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 70. GCC Countries Influenza Subunit Vaccine Revenue Growth 2019-2024 ($ millions) Figure 71. Manufacturing Cost Structure Analysis of Influenza Subunit Vaccine in 2023 Figure 72. Manufacturing Process Analysis of Influenza Subunit Vaccine Figure 73. Industry Chain Structure of Influenza Subunit Vaccine Figure 74. Channels of Distribution Figure 75. Global Influenza Subunit Vaccine Sales Market Forecast by Region (2025-2030) Figure 76. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Region (2025-2030) Figure 77. Global Influenza Subunit Vaccine Sales Market Share Forecast by Type (2025-2030) Figure 78. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Type (2025-2030) Figure 79. Global Influenza Subunit Vaccine Sales Market Share Forecast by Application (2025-2030) Figure 80. Global Influenza Subunit Vaccine Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Ab&B BIO-TECH"|||"Sanofi"|||"Seqirus|||Inc"|||"Zhongyianke Biology"